Example: Heart Attack

Clinical Trials on Hypereosinophilic Syndrome

Total 26 results

NCT03306043

Completed

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

Conditions: Hypereosinophilic Syndrome
NCT02836496

Completed

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Conditions: Hypereosinophilic Syndrome
NCT02581514

Recruiting

Eosinophilia Diagnosis

Conditions: Hypereosinophilic Syndrome
NCT04191304

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)

Conditions: Hypereosinophilic Syndrome
NCT02101138

Unknown status

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndrome
NCT01713504

Completed

Identification of New Markers in the Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndrome
NCT00171860

Terminated

A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndrome
NCT00244686

No longer available

This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic

Conditions: Hypereosinophilic Syndrome
NCT00097370

Terminated

Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndrome
NCT00017862

Completed

Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndrome
NCT04498871

Available

MAP to Provide Access to Nilotinib, for Patients With HES

Conditions: Hypereosinophilic Syndrome (HES)
NCT04018118

Recruiting

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

Conditions: Eosinophilia, Hypereosinophilic Syndrome
NCT00230334

Withdrawn

Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

Conditions: Eosinophilia, Hypereosinophilic Syndrome
NCT00091871

Recruiting

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Conditions: Eosinophilia, Hypereosinophilic Syndrome
NCT00086658

Completed

Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

Conditions: Hypereosinophilia, Hypereosinophilic Syndrome
NCT00044304

Recruiting

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

Conditions: Eosinophilic Myeloid Neoplasm, Hypereosinophilic Syndrome
NCT01524536

Completed

Steroid Treatment for Hypereosinophilic Syndrome

Conditions: Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder, Hematologic Diseases
NCT00787384

Completed

Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Conditions: Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia, Chronic Idiopathic Hypereosinophilia
NCT00276926

Unknown status

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Conditions: Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL), Myeloproliferative Disorders
NCT00171912

Completed

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Conditions: Hypereosinophilic Syndrome, Systemic Mastocytosis, Chronic Myelomonocytic Leukemia, Dermatofibrosarcoma
NCT00266565

Completed

Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

Conditions: Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis, Churg-Strauss Syndrome, Eosinophilic Esophagitis
NCT00038675

Completed

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Conditions: Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera, Hypereosinophilic Syndrome, Mastocytosis
NCT00109707

Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers

Conditions: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
NCT04538937

Recruiting

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils

Conditions: Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad, HES - Hypereosinophilic Syndrome, Eosinophilic Pneumonia
NCT00255346

Completed

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Agnogenic Myeloid Metaplasia, Myelofibrosis, Hypereosinophilic Syndrome, Polycythemia Vera, Mastocytosis, Leukemia, Myelomonocytic, Chronic